DecisionGateway
Feed Claims Forecasts Trajectories Domains Calendar Actors Places Labs
Beta
API Sign in
HomeClaimsEstimated savings are ₹3,541 crore, with 85 companies reporting revised MRPs for 121 drugs.
statement

Estimated savings are ₹3,541 crore, with 85 companies reporting revised MRPs for 121 drugs.

A statement by 85 companies. Statements are as reported by the cited publishers — not verified by DecisionGateway.

₹3,541 crore, with 85 companies reporting revised MRPs for 121 drugs
pib_backgroundersPublished 2026-11-10 Read source

Discussion

0/2000 Ctrl/⌘ + Enter

Related claims

Estimated savings are ₹3,357.49 crore (as on November 4, 2026), with 70 companies reporting revised MRPs for 120 drugs.post author · statement85 companies have submitted information on revised MRP for 121 drugs.post author · statementAs of 4 November 2026, 70 companies had announced revised MRPs for 120 medicines.post · statementThere will be a saving of ₹3,541 crore.post author · predictionEstimated savings amount to ₹3,357.49 crore (as of 4 November 2026).post · statementCompanies have reported an average of 50% to 75% in MRP reductions, with the highest at 96.45%.Companies · statement
All claims
FeedActorsForecasts